Acetazolamide vasoreactivity in vascular dementia: A positron emission tomographic study

European Neurology

Volumn 41, Issue 1, 1999, Pages 31-36

  De Reuck, J ^a   Decoo, D ^a   Hasenbroekx, M C ^a   Lamont, B ^a   Santens, P ^a   Goethals, P ^a,b   Strijckmans, K ^a,b   Lemahieu, I ^a,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Acetazolamide vasoreactivity; Cerebral blood flow; Lacunar dementia; Multi infarct dementia; Positron emission tomography

Indexed keywords

ACETAZOLAMIDE; AMMONIA; NITROGEN 13;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN METABOLISM; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROANGIOPATHY; MULTIINFARCT DEMENTIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THALAMUS;

ACETAZOLAMIDE; AGED; AGED, 80 AND OVER; AMMONIA; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DEMENTIA, MULTI-INFARCT; DEMENTIA, VASCULAR; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NITROGEN RADIOISOTOPES; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATION; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 0032949228     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007995     Document Type: Article

References (42)

1. Loeb C: Vascular dementia. Dementia 1990;1: 175-184.
2. Hachinski VC: Preventable senility: A call for action against the vascular dementias. Lancet 1992;340:645-648.
3. Treves TA, Aronovich BD, Bornstein NM, Korczyn AD: Risk of dementia after a first-ever ischemic stroke: A 3 year longitudinal study. Cerebrovasc Dis 1997;7:48-52.
4. Tatemichi TK: How acute brain failure becomes chronic: A view of the mechanisms of dementia related to stroke. Neurology 1990;40: 1652-1659.
5. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
6. Roman GG, Tatemichi TK, Erkinsjuntti T, et al: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 1993;43: 250-260.
7. Hachinski VL, Iliff LD, Zihkka E, et al: Cerebral blood flow in dementia. Arch Neurol 1975; 32:632-637.
8. Gold G, Giannokopoulos P, Montes-Paixao C, Herrmann FR, Mulligan R, Bouras C: Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997;49:690-694.
9. Pasquier F, Leys D: Why are stroke patients prone to develop dementia? J Neurol 1997; 244:135-142.
10. Hydra A, Scheltens Ph: Diagnostic criteria for vascular dementia; in Leys D, Scheltens Ph (eds): Vascular Dementia. Dordrecht, ICG, 1994, pp 3-8.
11. De Reuck J: Neuropathology of vascular dementia; in Leys D, Scheltens Ph (eds): Vascular dementia. Dordrecht, ICG, 1994, pp 9-17.
12. Frackowiak RSJ, Pozzilli C, Legg NJ, et al: Regional cerebral oxygen supply and utilisation in dementia. A clinical and physiological study with oxygen-15 and positron emission tomography. Brain 1981;104:753-778.
13. 18F scan in Alzheimer's disease and multiinfarct dementia. Arch Neurol 1983;40: 711-714.
14. Brown WD, Frackowiak RSJ: Cerebral blood flow and metabolism studies in multi-infarct dementia. Alzheimer Dis Assoc Disord 1991;5: 131-143.
15. Mazziota JC, Frackowiak RSJ, Phelps ME: The use of positron emission tomography in the clinical assessment of dementia. Semin Nucl Med 1992;22:233-246.
16. Mielke R, Pietrzyk V, Jacobs A, et al: HMPAO SPECT and FDG PET in Alzheimer's disease and vascular dementia: Comparison of perfusion and metabolic pattern. Eur J Nucl Med 1994;21:1052-1060.
17. De Reuck J: Evidence for chronic ischemia in the pathogenesis of vascular dementia. From neuroPATH to neuroPET. Acta Neurol Belg 1996;96:228-231.
18. De Reuck J, Decoo D, Marchau M, Santens P, Lemahieu I. Strijckmans K: Positron emission tomography in vascular dementia. J Neurol Sci 1998;154:55-61.
19. 2 reactivity in the ischaemic core, penumbra and normal tissue 6 hours after acute MCA-occlusion in primates. Acta Neurochir (Wien) 1993;125:150-155.
20. 123I-IMP single photon emission tomography in patients with major cerebral artery occlusive disease: Correlation with positron emission tomography parameters. J Cereb Blood Flow Metab 1994;14:763-770.
21. 15O-water measurement. Nucl Med Commun 1996;17:1047-1051.
22. Heiss WD, Podreka I: Role of PET and SPECT in the assessment of ischemic cerebrovascular disease. Cerebrovasc Brain Metab Rev 1993;5: 235-263.
23. Jacobs JW, Bernhard MR, Delgado A, Strain JJ: Screening for organic mental syndromes in the medically ill. Ann Intern Med 1977;86:40-46.
24. 3. Ann Neurol 1980;8:47-60.
25. Phelps ME, Huang SC, Hoffmann EJ, Selin C, Kuhl DE: Cerebral extraction of N-13-ammonia. Its dependence on cerebral blood flow and capillary permeability-surface area product. Stroke 1981;12:607-619.
26. Meguro K, Hatazawa J. Yamaguchi T, et al: Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging. Ann Neurol 1990;28:378-383.
27. Hatazawa J, Schimosegawa E, Satok T, Toyoshima H, Okudera T: Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging. Stroke 1997;28:1944-1947.
28. Fischer MC: The arterial lesions underlying lacunes. Acta Neuropathol (Berl) 1969;12:1-15.
29. De Reuck J, van der Eecken H: The arterial angioarchitecture in lacunar state. Acta Neurol Belg 1976;76:142-149.
30. Kobari M, Meyer JS, Ichyo M: Leuko-araiosis, cerebral atrophy and cerebral perfusion in normal ageing. Arch Neurol 1990;47:161-165.
31. De Reuck J, Van Aken J, Decoo D, et al: Cerebral blood flow and oxygen metabolism in leukoaraiosis. A positron emission tomography study. Cerebrovasc Dis 1991;1:25-30.
32. Kawamura J, Meyer JS, Taryama Y, Weathers S: Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke 1991; 22:609-614.
33. Leys D, Pruvo JP, Parent M, et al: Could Wallerian degeneration contribute to 'leukoaraiosis' in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry 1991;54:46-50.
34. De Reuck J, Decoo D, Strijckmans K, Lemahieu I: Does the severity of leukoaraiosis contribute to senile dementia? Eur Neurol 1992; 32:199-205.
35. Meyer JS, Takashima S, Terayama Y, et al: CT changes associated with normal aging in the human brain. J Neurol Sci 1994;123:200-208.
36. Sabri O, Hellwig D, Kaiser HJ, et al: Einfluss morphologischer Veränderungen auf Durchblutung und Stoffwechsel bei zerebraler Microangiopathie. Nucl Med 1995;34:50-56.
37. Reiche W, Weiller C, Weighmann R, et al: Vergleich von MRI- und SPECT-Befunden bei Patienten mit zerebralen Microangiopathie. Nucl Med 1991;30:161-169.
38. Kuwabara Y, Ischiya Y, Otsuka M, Masuda K, Ichimiya A, Fujishima M: Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswangertype. Stroke 1992;23:594-598.
39. Yao H, Sadoshima S, Kuwabara Y, Ichiya Y, Fujishima M: Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 1990;21:1694-1699.
40. De Reuck J, Decoo D, Lemahieu I, Strijckmans K, Goethals P: Is the leuko-araiosis dementia syndrome different from Binswanger's subcortical atherosclerotic encephalopathy? J Stroke Cerebrovasc Dis 1992;2:225-227.
41. Pullicino P, Benedict RHB, Capriso DK, Vella N, Withiam-Leitch S, Lee Kwen P: Neuro-imaging criteria for vascular dementia. Arch Neurol 1996;53:723-728.
42. Wilcock E, Morris J: Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry, 1997;63:749-753.